Home 5 Clinical Diagnostics Insider 5 FDA’s 2017 Priorities Emphasize Biomarkers and Precision Diagnostics

FDA’s 2017 Priorities Emphasize Biomarkers and Precision Diagnostics

by | Nov 29, 2016 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Top of the News-dtet

From - Diagnostic Testing & Emerging Technologies Precision medicine and biomarkers can help the U.S. Food and Drug Administration (FDA) ensure safety of… . . . read more

Subscribe to Clinical Diagnostics Insider to view

Start a Free Trial for immediate access to this article